Mar 12th, 2024

Novo Owner’s CEO on Obesity Sales Boom, Catalent Deal

Novo Holdings CEO Kasim Kutay discusses the surge in income from obesity drug sales and offers an update on the Catalent deal and insight on the company’s deal strategy.

Top Video

Explore More

Duration:23:44

Blackstone’s Gray on $26 Bln Bet That Felt 'Career Shortening'

Leaders with Francine Lacqua

Duration:1:48

Oil Jumps as Trump Rebuffs Iran’s Offer

Daybreak: Europe

Duration:3:08

US Citizens From Hantavirus Ship Isolated in Nebraska

Duration:2:40

Trump, Xi Slated for Beijing Summit

Duration:2:52

JPMorgan Says Equities at All-Time Highs 'Make Sense'

Duration:2:24

Brent Has Found an 'Uneasy Equilibrium,' StanChart Says

Duration:1:37

Starmer's UK Leadership Woes Add to Gilt Risks, Rabobank Says

Duration:1:50

Morgan Stanley’s Hornback Expects a ‘Spicier’ US Inflation Report

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.